Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents by Sun, Daekyu et al.
Facilitation of a structural transition in the
polypurine/polypyrimidine tract within the
proximal promoter region of the human VEGF
gene by the presence of potassium and
G-quadruplex-interactive agents
Daekyu Sun
1,*, Kexiao Guo
2, Jadrian J. Rusche
1 and Laurence H. Hurley
1,3,4
1College of Pharmacy,
2Department of Biochemistry and Molecular Biophysics and
3Department of
Chemistry, University of Arizona, Tucson, AZ 85721, USA and
4Arizona Cancer Center,
1515 N. Campbell Avenue, Tucson, AZ 85724, USA
Received August 3, 2005; Revised and Accepted October 4, 2005
ABSTRACT
The proximal promoter region of the human vascular
endothelial growth factor (VEGF) gene contains a
polypurine/polypyrimidine tract that serves as a
multiple binding site for Sp1 and Egr-1 transcription
factors. This tract contains a guanine-rich sequence
consisting of four runs of three or more contiguous
guanines separated by one or more bases, cor-
responding to a general motif for the formation of
an intramolecular G-quadruplex. In this study, we
observed the progressive unwinding of the oligomer
duplex DNA containing this region into single-
stranded forms in the presence of KCl and the
G-quadruplex-interactive agents TMPyP4 and
telomestatin, suggesting the dynamic nature of this
tract under conditions which favor the formation of
the G-quadruplex structures. Subsequent footprint-
ing studies with DNase I and S1 nucleases using a
supercoiled plasmid DNA containing the human
VEGFpromoter region also revealed along protected
region, including the guanine-rich sequences, in the
presence of KCl and telomestatin. Significantly, a
striking hypersensitivity to both nucleases was
observed at the 30-side residue of the predicted
G-quadruplex-forming region in the presence of KCl
and telomestatin, indicating altered conformation of
thehumanVEGFproximalpromoterregionsurround-
ing the guanine-rich sequence. In contrast, when
specificpointmutationswereintroducedintospecific
guanine residues within the G-quadruplex-forming
region (Sp1 binding sites) to abolish G-quadruplex-
forming ability, the reactivity of both nucleases
toward the mutated human VEGF proximal promoter
region was almost identical, even in the presence of
telomestatin with KCl. This comparison of wild-type
and mutant sequences strongly suggests that the
formation of highly organized secondary structures
such as G-quadruplexes within the G-rich region
of the human VEGF promoter region is responsible
for observed changes in the reactivity of both
nucleases within the polypurine/polypyrimidine
tract of the human VEGF gene. The formation of the
G-quadruplexstructuresfromthisG-richsequencein
the human VEGF promoter is further confirmed by
the CD experiments. Collectively, our results provide
strong evidence that specific G-quadruplex struc-
tures can naturally be formed by the G-rich sequence
within the polypurine/polypyrimidine tract of the
human VEGF promoter region, raising the possibility
that the transcriptional control of the VEGF gene can
be modulated by G-quadruplex-interactive agents.
INTRODUCTION
Thesizeofmostprimarysolidtumors isknowntobelimitedto
within  1–2 mm in diameter because the cancer cells initially
rely on pre-existing host blood vessels for a supply of oxygen
and nutrients (1). However, starving tumor cells can become
angiogenic by gaining the ability to direct the formation of
new blood vessels for their survival (2,3). The angiogenic
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doi:10.1093/nar/gki917switch in cancer cells is often initiated by increased expression
of vascular endothelial growth factor (VEGF), a pluripotent
cytokine and angiogenic growth factor (4). VEGF consists of
two identical subunits and binds to VEGF receptors on the
surfaces of endothelial cells (4). The interaction of VEGF and
its cognate receptors stimulates the proliferation, migration,
survival and permeability of endothelial cells, resulting in the
formation of new blood vessels (5). The formation of new
blood vessels adjacent to primary tumor sites promotes the
growth of cancer cells by providing oxygen and nutrients. In
addition, newly formed blood vessels serve as escape routes
for disseminating tumor cells, contributing to tumor metastasis
even in locations distant from the primary tumor site (5).
The expression of human VEGF, which is frequently
elevated in many types of cancer, is mainly regulated at the
transcriptional level (6,7). VEGF expression is induced by a
varietyoffactors, including hypoxia, pH, activated oncogenes,
inactivated tumor suppressor genes and growth factors (8–15).
The molecular basis of VEGF gene expression has been
extensively studied by characterizing the cis-acting elements
and transcription factors involved in constitutive VEGF
expression in human cancer cells (9–14). The human VEGF
promoter region contains putative binding sites for several
transcription factors, such as HIF-1, AP-1, AP-2, Egr-1,
Sp1 and many others, suggesting that they may be involved
in VEGF transcriptional regulation (13,14). Functional ana-
lysis of the human VEGF promoter using the full-length
VEGF promoter reporter revealed that the proximal 36 bp
region ( 85 to  50 relative to transcription initiation site)
is essential for basal or inducible VEGF promoter activity in
several human cancer cells (13,14). This region contains at
least three Sp1 binding sites, each consisting of a polypurine/
polypyrimidine tract (Figure 1). Although there are binding
sites for other factors, such as two Egr-1 elements and one
AP-2 element, all Sp1 binding sites were found to be func-
tionally signiﬁcant in constitutive VEGF promoter activity
(13,14). Polypurine/polypyrimidine tracts are also found in
the promoter region of other growth-related genes, including
Hmga-2, EGF-R, c-Myc, I-R, AR, c-Src, c-Ki-Ras, TGF-b,
PDGF A-chain, insulin and muscle-speciﬁc protein (16–25).
These sequences have been proposed to be very dynamic in
their conformation, easily adopting non-B-DNA conforma-
tions, such as melted DNA, hairpin structures, slipped helices,
or others, under physiological conditions (16–25). These
sequences also provide landing sites for a transcription
machinery complex to initiate transcriptional activation of
these genes (26,27). In particular, the guanine-rich sequences
found in the polypurine/polypyrimidine tracts are known to
form G-quadruplex structures consisting of two or more
G-tetrads in the presence of monovalent cations such as
Na
+ and K
+ under physiological conditions as shown in
Figure 2A (28,29). Recently, both NMR and X-ray crystallo-
graphy studies have determined the structures of various forms
of G-quadruplexes, and these studies have revealed that fold-
ing patterns of these G-quadruplexes depend on the precise
arrangement and composition of G-repeats, as well as on the
size of the intervening sequences (30–36). Signiﬁcantly, the
polypurine tract of the VEGF promoter consists of ﬁve runs of
at least three contiguous guanines (GR-I to GR-V in Figure 1)
separated by one or more bases, conforming to the general
motif capable of forming G-quadruplex structures. Therefore,
we hypothesized that the polypurine/polypyrimidine tract of
the VEGF promoter region is very dynamic in its structure and
can easily adopt a non-B-DNA conformation under physiolo-
gical conditions.Moreover, wepredictedthatthe G-richstrand
of this tract could form speciﬁc G-quadruplex structures in the
presence of K
+ or G-quadruplex-interactive agents.
To test our hypothesis, we initially used a DNA breathing
assay with an oligomer duplex containing the polypurine/
polypyrimidine tract in the VEGF promoter. We anticipated
that the unwinding of this oligomer duplex could be facilitated
in the presence of G-quadruplex-interactive agents by trapping
out and stabilizing the G-quadruplex transiently formed by
the G-rich strand of the polypurine/polypyrimidine tract. In
addition, we used DNase I and S1 nuclease footprinting to
study the structural transition within this tract of the VEGF
promoter, since the activity of these enzymes is modulated by
DNA conformation (16–18).
In this article, we demonstrate that G-quadruplex-
interactive agents promote the unwinding of the oligomer
duplex containing the polypurine/polypyrimidine tract in the
presence of K
+. Footprinting experiments with DNase I and S1
Figure1.Polypurine/polypyrimidinesequencelocatedupstream( 89to 43)ofthepromoterregionoftheVEGFgene.Runsofguanines(GR-IthroughGR-V)are
boxed. Binding sites of the transcriptional factors Egr-1 and Sp1 are underlined.
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wild-type or mutant VEGF promoters revealed that the
emergence of DNase I and S1 nuclease cleavage in the vicinity
of the polypurine/polypyrimidine tract was dependent on both
the capability of the wild-type sequence to form G-quadruplex
structures and the presence of K
+ and G-quadruplex-
interactive compounds. Collectively, these results support
the conclusion that G-quadruplex structures form within
this polypurine/pyrimidine tract of the VEGF promoter.
MATERIALS AND METHODS
Drugs, enzymes and oligonucleotide DNA
TMPyP4 was purchased from Midwest Chemicals, and
telomestatin was kindly provided by Dr Kazuo Shin-ya
(University of Tokyo, Japan). Both drug molecules were dis-
solved in dimethyl sulfoxide, unless otherwise speciﬁed. T4
nucleotide kinase and Taq DNA polymerase were purchased
from Promega. PAGE-puriﬁed oligonucleotides were obtained
from Sigma Genosys.
Polymerase stop assay
The primer DNA (P28) was 50 end-labeled using T4 polynuc-
leotide kinase with [g-
32P]ATP (3000 Ci/mmol, Perkin Elmer)
for 1 h at 37 C and puriﬁed on a Bio-Spin 6 chromatography
column (BioRad) after inactivation of the kinase by heating at
95 C for3 min. Labeled primers were annealed to the template
DNA and the primer-annealed template DNA was separated
from excess labeled primer or remaining template DNA using
non-denaturing 8% PAGE. The resulting primer-annealed
template DNA was gel-puriﬁed and used as a substrate in a
primer extension assay by Taq DNA polymerase, as described
previously (37).
DNA breathing assay
We designed a 59 bp oligo duplex DNA (59WT) containing
the Sp1 binding sites ( 101 to  43, relative to transcriptional
start site) of the VEGF promoter region (see Figure 3A) in
order to study the dynamic features of this promoter region.
For the DNA breathing assay, the top strand of 59WT DNA
was 50 end-labeled with
32P and incubated with increas-
ing concentrations of TMPyP4 or telomestatin in 150 mM
KCl/TE buffer for 10 h at 37 C. The reaction also contained
an 8-fold molar excess of unlabeled top (G-rich) strand as a
trap to prevent the released (labeled with
32P) top strands from
reannealing, and the DNA was electrophoresed on an 8%
native polyacrylamide gel to separate other species of DNA
from the duplex form of DNA.
Plasmid DNA
For in vitro footprinting of the VEGF promoter region, we
used the supercoiled form of the luciferase reporter plasmid
pGL3-VEGFP, which was constructed by ligating an 837 bp
VEGF promoter region ( 787 to +50 relative to the transcrip-
tion initiation site) into the KpnI and NheI sites of pGL3-basic
basic vector (Promega, Madison, WI), as described previously
(14). This region of the VEGF promoter was found to support
the transcription of luciferase expression in human cancer
cell lines (14). A mutant reporter plasmid, pGL3-VEGFM17,
was constructed by introducing point mutations into speciﬁc
guanine residues within the Sp1 binding sites of the VEGF
promoter regions of pGL3-VEGFP using a QuickChange
mutagenesis kit (Stratagene) to destabilize or abolish the
G-quadruplex-forming ability of this region.
In vitro footprinting of the VEGF promoter region with
DNase I and S1 nuclease
A supercoiled form of each of the plasmids (pGL3-VEGFP
and pGL3-VEGFM17) was incubated in the absence of any
salt, or in the presence of 100 mM KCl with and without 1 mM
telomestatin as a selective G-quadruplex-interactive agent at
37 C for 1 h and then treated with DNase I or S1 nuclease for
2 min. DNA was precipitated with ethanol and resuspended in
double-distilled water after vacuum drying. To map DNase I
and S1 nuclease cleavage sites on the plasmid DNA, linear
ampliﬁcation by PCRwasperformedusingThermo Sequenase
Cycle Sequencing kit (USB) with
32P-labeled gene-
speciﬁc primers d(CCCAGCGCCACGACCTCCGAGC-
TACC) and d(CTGTGAACCTTGGTGGGGGTCGAGC) to
amplify the top and bottom strands of the plasmid DNA,
respectively.
Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded on a Jasco-810
spectropolarimeter (Jasco, Easton, MD), using a quartz cell of
Figure 2. (A) H-bonding pattern in a G-tetrad, (B) schematic diagram of the G-tetrad and (C) cartoon of an 18mer parallel G-quadruplex representing that found
in the c-MYC promoter region.
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100 nm/min, with a response time of 1 s and over a wavelength
range of 200–330 or 200–600 nm for the titration experiments
with drugs. All DNA samples were dissolved in Tris–HCl
buffer (20 mM, pH 7.6) to a strand concentration of 5 mM,
and where appropriate, the samples also contained 100 mM
KCl. The CD spectra herein are representations of four aver-
aged scans taken at 25 C and are baseline corrected for signal
contributions due to the buffer.
RESULTS
Transition of duplex to a non-B-DNA conformation
withinthepolypurine/polypyrimidinetractoftheVEGF
promoter region in the presence of TMPyP4 and
telomestatin
In order to test if the polypurine/polypyrimidine tract of the
VEGF promoter region is structurally dynamic and can easily
adopt a non-B-DNA conformation under physiological
conditions, a DNA breathing assay was carried out with a
59 bp oligomer duplex (59WT) containing the polypurine/
polypyrimidine tract (Figure 3A). It was anticipated that
the unwinding of the 59WT would occur if Watson–Crick
base pairs are destabilized by the formation of non-B-DNA
structures in the Sp1 binding sites of the VEGF promoter
region. In the DNA breathing assay, the oligomer duplex
(59WT) labeled at the 50 end of the G-rich strand with
32P
was incubated with increasing concentrations of the G-
quadruplex-interactive agents TMPyP4 (38) or telomestatin
(39) (Figure 3B) at 37 C in the presence of 150 mM KCl
and then electrophoresed on an 8% native polyacrylamide
gel to separate other species of DNA from the duplex form
of DNA. G-quadruplex-interactive agents were included to
determine if these agents promote the unwinding process by
further stabilizing and trapping out the G-quadruplex struc-
tures formed by the G-rich strand. As shown in Figure 3C
and D, the formation of a single-stranded DNA species was
progressively increased as the concentrations of TMPyP4 and
telomestatin were increased. TMPyP4 and telomestatin will
prevent the conversion back to a B-DNA structure by trapping
out and stabilizing the G-quadruplex structures formed in
this region of the VEGF promoter. The results from the
DNA unwinding study support the idea that the polypurine/
polypyrimidine tract of the VEGF promoter region is very
dynamic in its structure, and G-quadruplex structures can
beformed bythe G-richstrand ofthistract under physiological
conditions of potassium, pH and temperature with the addition
of G-quadruplex-stabilizing agents.
Figure 3. The effect of increasing TMPyP4 and telomestatin concentrations on the conversion of 59mer duplex DNA (59WT) to alternative secondary structures.
(A)Nucleotidesequenceof59WT.(B)StructuresofTMPyP4andtelomestatin.(C)AutoradiogramofDNAbreathingassay.DuplexDNAwastitratedwithTMPyP4
ortelomestatinin100mMKCl/TEbufferat37or42 C.TwobandscorrespondingtoWatson–Crickduplex(DS)andsingle-strandedDNA(S)wereidentified,along
with an isomeric form. (D) Graphical representation of data described in (C).
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contained in a plasmid in the presence of K
+ and
G-quadruplex-interactive compounds
DNase I and S1 nucleases have been previously used as tools
for studying structural transitions occurring in normal B-type
DNA (16–18). For example, while DNase I preferentially
cleaves locally unwound or normal duplex regions over
single-stranded regions, S1 nuclease preferentially cleaves
single-stranded regions of DNA over duplex DNA (16–24).
However, both enzymes show the lowest cleavage activity
toward highly organized secondary structures such as hairpins
or G-quadruplex structures. For these reasons, the existence
of a non-B-conformation can be implied from changes in the
pattern of DNase I and S1 nuclease sensitivity of certain
regions of DNA (16–24).
DNase I cleavage. DNase I footprinting was used to determine
the possible structural transition from B-DNA to non-B-type
DNA structures in the promoter region of the VEGF gene. For
the DNase I footprinting, the plasmid pGL3-VEGFP, which
contains the VEGF promoter region from  787 to +50, was
incubated either in the absence of salt or in the presence of
100 mM KCl, with and without 1 mM telomestatin as the
selective G-quadruplex-interactive agent, at 37 C for 1 h
and then treated with DNase I for 2 min. DNase I cleavage
sites in the plasmids were then mapped using linear ampliﬁca-
tion by PCR with
32P-labeled gene-speciﬁc primers. The pri-
mer extension reaction carried out on the top strand of the
plasmid revealed a long DNase I protected region located at
approximately  53 to  123 bp, which includes the G-rich
sequences, when the supercoiled pGL3-VEGFP plasmid was
incubated with 100 mM KCl (Figure 4A and B; compare
lanes 2 and 3 with lane 1). This result is in accord with a transi-
tion from B-DNA to a non-B-DNA structure in the VEGF
promoter region, which is most probably a G-quadruplex
and consequently resistant to DNase I digestion. Signiﬁcantly,
a striking DNase I hypersensitivity was found at a cytosine
located at the 30-side of the predicted G-quadruplex-forming
region in the presence of KCl and telomestatin, which is
most probably associated with the junction site between the
G-quadruplex and the adjacent normal B-DNA (arrow A in
Figure 4A and B). The primer extension reaction of the bottom
strand of the plasmid revealed that the reactivity of DNase I on
the C-rich region in the VEGF promoter was moderately
reduced in the presence of KCl and KCl with telomestatin
(Figure 4C; compare lanes 2 and 3 with lane 1). This result
suggests that the C-rich sequence and the surrounding region
of the VEGF promoter might exist in single-stranded form as
a result of the transition of purine-rich strand in the B-type
DNA structure to a G-quadruplex under these conditions.
Figure 4. In vitro footprinting of the VEGF promoter region with DNase I. (A) Autoradiograms showing DNase I cleavage sites on the top strand of a supercoiled
pGL3-VEGF plasmid. The plasmid DNA was incubated in the absence of salt (lane 1), or in the presence of 100 mM KCl without (lane 2) and with (lane 3) 1 mM
telomestatin at 37 C for 1 h before digesting with DNase I. DNase I cleavage sites were mapped using linear amplification by PCR with
32P-labeled gene-specific
plasmid DNA pretreated with DNase I. Arrows A and B indicate the hypersensitive cleavage sites to nucleases. (B) Densitometric scanning of the autoradiogram
in (A). The bars indicate the guanine repeats involved in the formation of the G-quadruplex structures. Arrows A and B indicate the hypersensitive cleavage sites
to nucleases. (C) Autoradiograms showing DNase I cleavage sites on the bottom strand of a supercoiled pGL3-VEGF plasmid. The designation of lanes 1–3 was
as in (A) above. DNase I cleavage sites were mapped using linear amplification by PCR with
32P-labeled gene-specific plasmid DNA pretreated with DNase I.
The vertical bar next to the gel indicates the polypyrimidine tract.
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be caused by either the presence of a single-stranded region or
a highly organized secondary structure, such as G-quadruplex
structures within the polypurine/polypyrimidine tract of the
VEGF promoter, an additional footprinting experiment using
S1 nuclease was carried out to obtain further detailed infor-
mation about the conformational transition occurring in this
region. As shown in Figure 5A and B, the reactivity of S1
nuclease on the top strand of the polypurine/polypyrimidine
tract of the VEGF promoter was markedly reduced in the
presence of KCl with telomestatin. The reduced reactivity of
the VEGF promoter region surrounding the G-quadruplex-
forming region to both DNase I and S1 nuclease suggests
the formation of highly organized secondary structures,
such as G-quadruplex structures, rather than the formation
of a single-stranded form in the G-rich region of the VEGF
promoter in the presence of KCl with telomestatin. Signiﬁc-
antly, the hypersensitivity site observed with S1 nuclease also
corresponds to that obtained with DNase I in the presence
of KCl with telomestatin. The presence of this common
hypersensitivity site to both nucleases at the 30-side of the
G-quadruplex-forming region is a strong indicator of the
enhanced exposure of this particular residue to both nucleases,
suggesting the presence of a junction site between the B-type
DNA structure and the G-quadruplex at this site in the pro-
moter region of the VEGF gene. In contrast, the reactivity
to S1 nuclease of the opposite strand of the same region
was moderately enhanced, with the hypersensitive region
extending upstream of the G-rich tract (see arrows in
Figure 5C). These results suggest that the opposite strand of
the G-rich sequence and the surrounding region of the VEGF
promoter exists in a single-stranded form as a result of the
transition of B-type DNA structure to the G-quadruplexes
under the conditions that favor such transitions.
Comparison of the abilities of the G-rich strands of the
wild-type versus mutant VEGF promoter sequences
to form stable G-quadruplex structures
In order to demonstrate the G-quadruplex-forming ability of
the G-rich strand of the polypurine/polypyrimidine tract in the
presence of KCl, a DNA polymerase stop assay was used, as
previously described (37). This assay provides a simple and
rapid way to identify DNA secondary structures, such as
G-quadruplexes, in vitro, based on the principle that DNA
polymerase is incapable of traversing these structures
(37,38). Thus, the DNA polymerase, traversing toward the
50 end of the template and unable to efﬁciently resolve quad-
ruplex DNA, pauses or stops 30 to the ﬁrst guanine involved in
a stable G-quadruplex. When a DNA template (WT) contain-
ing the G-quadruplex-forming region [d(G4CG3C2G5CG4)]
was annealed with
32P-labeled primers and incubated with
Taq DNA polymerase, a potassium-dependent pause of the
DNA polymerase extension was observed with this DNA tem-
plate (Figure 6A). In contrast, in the absence of KCl, the DNA
polymerase bypasses the G-repeat region. The KCl-dependent
Figure 5. In vitro footprinting of the VEGF promoter region with S1 nuclease. (A) Autoradiograms showing S1 nuclease cleavage sites on the top strand of a
supercoiledpGL3-VEGFplasmid.ArrowAindicatesthehypersensitive cleavage sitestoS1nuclease.(B)Densitometricscanningoftheautoradiogramin(A).The
plasmidDNAwasincubatedintheabsenceofsalt(lane1)orinthepresenceof100mMKClwithout(lane2)andwith(lane3)1mMtelomestatinat37 Cfor1hbefore
digesting with S1 nuclease. S1 nuclease cleavage sites were mapped using linear amplification by PCR with
32P-labeled gene-specific primers on plasmid DNA
pretreatedwithS1nuclease.ArrowAindicatesthehypersensitivecleavagesitestoS1nuclease.(C)AutoradiogramsshowingS1cleavagesitesonthebottomstrand
of a supercoiled pGL3-VEGF plasmid. The designation of lanes 1–3 was as in (A) above. The vertical bar next to the gel indicates the polypyrimidine tract and the
arrows indicate the S1 nuclease hypersensitivity sites.
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(GR-IV), presumably through stabilization of the intramolecu-
lar G-quadruplex structure, conﬁrming that this region is
indeed capable of forming intramolecular G-quadruplex struc-
tures (Figure 6A). A potassium-dependent pausing of DNA
polymerase extension was not observed in the mutant DNA
template (MT), in which mutations were introduced into the
G-quadruplex-forming region to abolish the formation of
G-quadruplex structures (Figure 6B).
In vitro footprinting of the mutant VEGF promoter
region with DNase I and S1 nuclease
The importance of the G-quadruplex-forming ability of the
polypurine/polypyrimidine tract in causing the change in
the reactivity of both nucleases in the presence of KCl and
telomestatin was determined using the mutant reporter
plasmid pGL3-VEGFM17. This plasmid contains the same
point mutations in the speciﬁc guanine residues within the
G-quadruplex-forming region of the VEGF promoter as those
showninFigure 6BtodestabilizeorabolishtheG-quadruplex-
forming ability of this region. For in vitro footprinting, the
supercoiled form of the mutant plasmid pGL3-VEGFM17
was incubated under the same conditions and with the same
enzymes used in the previous experiments shown in Figures 4
and 5. As shown in Figure 7, the reactivity of both nucleases
toward the mutated VEGF proximal promoter region was
little changed in the presence of telomestatin with KCl,
and the hypersensitivity site was not observed with both
nucleases in the presence of telomestatin with KCl. This result
providesstrongsupportfortheideathattheformationofhighly
organized secondary structures, such as G-quadruplex struc-
tures, within the G-rich region of the VEGF promoter region
is responsible for observed changes in the DNase I and S1
cleavage reactivity of the polypurine/polypyrimidine tract in
the human VEGF promoter sequence.
CD spectra of the G-rich strand in the VEGF promoter
reveals a parallel-stranded G-quadruplex
CD spectroscopy has been widely used to infer the presence of
G-quadruplexes and is particularly useful for differentiating
parallel and antiparallel G-quadruplexes (40,41). All guano-
sines in the structure of a parallel quadruplex have an anti-
conformation of the glycosyl bonds, resulting in a positive
band at  265 nm and a small negative band at  245 nm in
CD spectrum (40,41). In contrast, the guanosines in an anti-
parallel quadruplex have alternating syn and anti glycosyl
conformations along each strand, exhibiting a positive band
at  295 nm that is associated with an antiparallel strand
arrangement. The oligonucleotide used in CD studies was
VEGF-PuT, d(T5G3CG3C2G5CG3T5), which contains a poten-
tial G-quadruplex forming region [d(G3CG3C2G5CG3)] of
the G-rich strand in the VEGF promoter. As shown Figure 8,
the CD spectra of this sequence displays the characteristic
signature for the parallel-type of G-quadruplex in the presence
Figure 6. DNA polymerase stop assay to determine the ability of the VEGF promoter to form G-quadruplex structures. (A and B) The wild-type (WT) and mutant
(MT) template sequences (shown below the gels) with increasing concentrations of K
+ (0–100 mM). Arrows indicate the positions of the full-length product
(F)of DNA synthesis, the G-quadruplex pause site(S), and the free primer(P). Lanes A, G,T and C represent dideoxysequencing reactionswiththe same template
as a size marker for the precise arrest sites.
6076 Nucleic Acids Research, 2005, Vol. 33, No. 18of increasing concentration of KCl, exhibiting a positive band
at  265 nm and a small negative band at  245 nm.
DISCUSSION
The proposed transition of B-DNA into non-B-DNA struc-
tures, such as melted DNA, hairpin structures, slipped helices
or others, has been reported in a number of growth-related
mammalian genes, including Hmga2, EGF-R, c-Myc, malic
enzyme, I-R,AR,c-Src,c-Ki-Ras, TGF-b,sMtCK, a7integrin
and PDGF A-chain (16–25). Signiﬁcantly, the polypurine/
polypyrimidinetractsare oftenfoundinthe proximalpromoter
region of these genes, implicating the importance of structural
transitions in these DNA tracts in mediating transcriptional
regulation of these genes (16–24). In general, DNA unwinding
at the proximal promoter region of both prokaryotic and euka-
ryotic genes is believed to enhance open promoter complex
formation with transcriptional machineries leading to tran-
scriptional activation of the genes (26,27). A polypurine/
polypyrimidine tract was also found within the proximal pro-
moter region of the VEGF gene, the gene product of which is
an angiogenic growth factor. This tract is known to serve as a
multiple binding site for Sp1 and Egr-1 transcription factors
(13,14). The polypurine tract of the VEGF promoter region
contains a guanine-rich sequence consisting of four runs of
three or more contiguous guanines separated by one or
more bases. This guanine-rich sequence conforms to a general
motif capable of forming an intramolecular G-quadruplex:
GxNyGxNyGxNyGx, where x > 3 and y > 1 (28,29). There-
fore, in this study, we were interested in addressing whether
a conformational transition exists among B-type DNA, melted
DNA and G-quadruplex structures within this tract in the
VEGF promoter, and whether speciﬁc G-quadruplex struc-
tures can naturally form from the guanine-rich sequence
of this tract in the presence of KCl and/or G-quadruplex-
interactive agents. We anticipated that the results of this
study would enhance our understanding of the role of DNA
structure in transcriptional regulation of the VEGF gene.
Furthermore, we wished to explore a new therapeutic strategy
to treat tumor angiogenesis by repressing the transcriptional
activation of a major angiogenic gene, VEGF, by modiﬁcation
or stabilization of non-canonical DNA structures such as
G-quadruplexes with G-quadruplex-interactive drugs.
In this report, the dynamic nature of a polypurine/
polypyrimidine tract of the VEGF promoter region has been
demonstrated through a DNA breathing assay using the
Figure 7. In vitro footprinting of the mutant VEGF promoter region with
DNase I and S1 nuclease. Autoradiograms showing DNase I (lanes 1–3) and
S1 (lanes 4–6) cleavage sites on the top strand of a supercoiled pGL3-
VEGFM17 plasmid. This plasmid was incubated in the absence of salt
(lanes 1 and 4) or in the presence of 100 mM KCl without (lanes 2 and 5)
and with (lanes 3 and 6) 1 mM telomestatin at 37 C for 1 h before digesting
withnucleases.Nucleasecleavagesitesweremappedusinglinearamplification
by PCR with
32P-labeled gene-specific primers on mutant plasmid DNA
pretreated with S1 nuclease or DNase I.
Figure 8. CDspectraoftheVEGF-Pu20T,d(T5G3CG3C2G5CG3T5),inTris–HClbuffer(20mM,pH7.6)inthepresenceofincreasingconcentrationsofKCl(0,10,
50 and 100 mM). Each spectrum corresponds to four averaged scans taken at 25 C and is baseline corrected for signal contributions due to the buffer.
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telomestatin, which are two representative G-quadruplex-
interactive agents, were found to promote the unwinding of
this oligomer duplex in the presence of KCl (150 mM) under
physiological conditions (see Figure 3). We propose that these
agents can trap out and stabilize the G-quadruplex structures
that are transiently formed from the unwound G-rich strand of
the 59mer duplex, facilitating the unwinding of the oligomer
duplex into single-stranded forms. The destabilization of
the proximal region of the VEGF promoter may contribute
to the transcriptional activation of the VEGF gene by provid-
ing the binding site for transcriptional machinery, including
transcriptional factors (e.g. CNBP or hnRNP, which are
single-stranded DNA-binding proteins) and RNA polymerase
in the TATA-less promoter region (40). The results from our
footprinting studies using DNase I and S1 nuclease also
demonstrate that the VEGF promoter region including the
guanine-rich sequences adapts an unusual DNA conformation.
In general, locally unwound or normal duplex regions are
preferentially cleaved by DNase I over single-stranded regions
or highly organized secondary structures such as hairpins or
G-quadruplex structures (16–18). In contrast, S1 nuclease pre-
fers to cleave single-stranded or locally unwound regions
of duplex DNA over normal duplex and highly organized
secondary structures. Therefore, the combined use of both
nucleases in in vitro footprinting experiments is expected to
reveal pertinent information about unusual structural features
of deﬁned elements within the global region of DNA duplex
molecules. A summary of the results from the DNase I and
S1 nuclease footprinting experiments is shown in Figure 9.
The DNA cleavage results from our footprinting studies
revealed a long protected region including the guanine-rich
sequences by both nucleases in the presence of KCl and
telomestatin, which are known to facilitate the transition of
B-type DNA structures to G-quadruplexes. Signiﬁcantly, a
striking hypersensitivity to both nucleases was observed at
the 30 side residue of the predicted G-quadruplex-forming
region in the presence of KCl and telomestatin, indicating
an altered conformation of the VEGF proximal promoter
region surrounding the guanine-rich sequence. It is important
to note that the identical changes in footprinting patterns
by both nucleases in the presence of KCl are signiﬁcantly
enhanced by the presence of the G-quadruplex-interactive
agent telomestatin, suggesting that telomestatin interacts
with G-quadruplex structure(s) formed by the G-rich sequence
within the polypurine/polypyrimidine region. Finally, since
speciﬁc point mutations introduced into speciﬁc guanine
residues within the G-quadruplex-forming region abolished
G-quadruplex-forming ability, and correspondingly, the react-
ivity of both nucleases toward the mutated VEGF proximal
promoter region was little changed, even in the presence of
telomestatin with KCl, these results also provide solid evid-
ence that the formation of G-quadruplex structures within the
G-rich region of the VEGF promoter region is responsible for
observed changes in the reactivity of both nucleases within the
polypurine/polypyrimidine tract of the human VEGF gene.
The result from CD spectroscopy suggests that the
secondary structures formed by the G-rich strand,
d(G4CG3C2G5CG4), of the VEGF promoter could be the par-
allel type of intramolecular G-quadruplex. Our electrophoretic
mobility shift assay indicated that this sequence predomin-
antly formed an intramolecular G-quadruplex structure in
the presence of KCl (D. Sun, unpublished data). The structure
of G-quadruplexes formed by this oligonucleotide is predicted
to be very similar to that found in the C-MYC G-quadruplex
structures (34). In this mutant sequence derived from the
NHEIII1 in the c-MYC promoter, the central run of guanines
is substituted in the four thymines (34). This structure involves
a core of three stacked G-tetrads formed by four G-stretches
and three loops bridging three G-tetrad layers (34). The central
loop contains six residues, while the two other loops contain
only one residue.
Previous studies reported that certain types of G-rich
sequences are capable of forming parallel or antiparallel G-
quadruplex structures consisting of two or more G-tetrads
in the presence of monovalent cations such as Na
+ and K
+.
G-rich sequences capable of forming G-quadruplexes have
been reported in telomeric sequences, immunoglobulin switch
regions, the insulin gene, the control region of the retino-
blastoma susceptibility gene, the promoter region of the
c-Myc gene, fragile X syndrome triplet repeats, and HIV-1
RNA [(reviewed in (36)] and muscle-speciﬁc protein (25).
Recently, the solution structure of the parallel G-quadruplex
in the c-Myc promoter was determined (35). Direct evidence
for the existence of G-quadruplexes in vivo is beginning to
emerge, and the ability of these important sequences to form
very stable G-quadruplex structures in vitro suggests that
G-quadruplex DNA may play an important role in several
biological events (34). For instance, a recent study provided
compelling evidence that a speciﬁc G-quadruplex structure
formed in the c-Myc promoter functions as a transcriptional
repressor element, establishing the principle that c-Myc
transcription could be controlled by ligand-mediated
G-quadruplex stabilization (42). Analogous to the c-Myc
gene, the transcription of the VEGF gene could be regulated
by the G-quadruplex structures formed by the G-rich sequence
within the polypurine/polypyrimidine tract of the promoter
region. G-quadruplex structures could inhibit the interaction
of transcriptional factors (e.g. Sp1) with their cognate sites
if those sites overlap the G-quadruplex-forming region.
Figure 9. Summary of the results from both DNase I and S1 nuclease footprinting (Figures 4 and 5). The arrow heads and filled circles indicate the hypersensitive
sites to S1 nuclease and DNase I, respectively.
6078 Nucleic Acids Research, 2005, Vol. 33, No. 18Alternatively, the formation of G-quadruplex structures
could induce DNA bending at the junction sites between
G-quadruplex structures and normal B-DNA structures,
potentially leading to the activation or repression of transcrip-
tion. Future studies are directed toward addressing whether
mutation of sequences of the polypurine/polypyrimidine tract
could lead to transcriptional repression (or activation) of the
VEGF promoter, and if the G-quadruplex-forming ability of
this region correlates with the promoter activity of the VEGF
genes.
In summary, our results provide strong evidence that
speciﬁc G-quadruplex structures can naturally be formed by
the G-rich sequence within the polypurine/polypyrimidine
tract of the VEGF promoter region, raising the possibility
that the transcription of this gene can be controlled by
ligand-mediated G-quadruplex stabilization.
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